Literature DB >> 4008636

Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.

A K Lefvert, R Pirskanen, E Svanborg.   

Abstract

Fifty-eight first-degree relatives to 40 patients with myasthenia gravis were investigated regarding presence of acetylcholine receptor antibodies, anti-idiotypic antibodies against the receptor antibodies and clinical and electrophysiological signs of disturbed neuromuscular function. No relative had clinical signs of muscle weakness. The prevalence of low concentrations of receptor antibodies was 54%, of anti-idiotypic antibodies 37% and of pathological and borderline single fibre EMG 45%. No sibling, only 2/11 children and 3/14 parents were normal in all three tests. A combination of receptor antibodies and anti-idiotypic antibodies was the most common finding and was especially frequent in children. In female siblings and children there was a positive correlation between the presence of HLA-antigen A1 and/or B8 and that of receptor antibodies and anti-idiotypic antibodies. Male siblings and children showed no such correlation but had a higher frequency of pathological single fibre EMG than females.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008636     DOI: 10.1016/s0165-5728(85)80005-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

2.  Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.

Authors:  Priya Sakthivel; Xiongbiao Wang; Baback Gharizadeh; Ricardo Giscombe; Ritva Pirskanen; Pål Nyren; Ann Kari Lefvert
Journal:  J Genet       Date:  2006-12       Impact factor: 1.166

Review 3.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 4.  Idiotypes and autoimmunity.

Authors:  D K Male
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

Review 5.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

6.  Antiidiotypic antibodies against anti-DNA antibodies in sera of families of lupus patients.

Authors:  N I Abdou; R Suenaga; M Hatfield; M Evans; K M Hassanein
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

7.  Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis.

Authors:  H J Garchon; F Djabiri; J P Viard; P Gajdos; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Myasthenia gravis associated with Charcot-Marie-Tooth neuropathy: report of a case.

Authors:  G Salemi; B Fierro; G Savettieri; M Maggio; I Lupo; S Ferrari; F Piccoli
Journal:  Ital J Neurol Sci       Date:  1992-06

9.  Clinical implementation of anti-acetylcholine receptor antibodies.

Authors:  F E Somnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

10.  Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.

Authors:  L Liao; R Sindhwani; M Rojkind; S Factor; L Leinwand; B Diamond
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.